First-in-Human Randomized Study to Assess the Safety and Immunogenicity of an Investigational Respiratory Syncytial Virus (RSV) Vaccine Based on Chimpanzee-Adenovirus-155 Viral Vector-Expressing RSV Fusion, Nucleocapsid, and Antitermination Viral Proteins in Healthy Adults.
Saved in:
| Title: | First-in-Human Randomized Study to Assess the Safety and Immunogenicity of an Investigational Respiratory Syncytial Virus (RSV) Vaccine Based on Chimpanzee-Adenovirus-155 Viral Vector-Expressing RSV Fusion, Nucleocapsid, and Antitermination Viral Proteins in Healthy Adults. |
|---|---|
| Authors: | Cicconi P; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, United Kingdom., Jones C; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, United Kingdom., Sarkar E; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, United Kingdom., Silva-Reyes L; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, United Kingdom., Klenerman P; Nuffield Department of Medicine, University of Oxford, United Kingdom., de Lara C; Nuffield Department of Medicine, University of Oxford, United Kingdom., Hutchings C; Nuffield Department of Medicine, University of Oxford, United Kingdom., Moris P; GSK, Rixensart, Belgium., Janssens M; GSK, Rixensart, Belgium., Fissette LA; GSK, Wavre, Belgium., Picciolato M; GSK, Rixensart, Belgium., Leach A; GSK, Rockville, Maryland., Gonzalez-Lopez A; GSK, Rockville, Maryland., Dieussaert I; GSK, Rockville, Maryland., Snape MD; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, United Kingdom.; National Institute for Health Research Oxford Biomedical Centre, United Kingdom. |
| Source: | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2020 May 06; Vol. 70 (10), pp. 2073-2081. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 31340042 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: First-in-Human Randomized Study to Assess the Safety and Immunogenicity of an Investigational Respiratory Syncytial Virus (RSV) Vaccine Based on Chimpanzee-Adenovirus-155 Viral Vector-Expressing RSV Fusion, Nucleocapsid, and Antitermination Viral Proteins in Healthy Adults. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Cicconi+P%22">Cicconi P</searchLink>; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Jones+C%22">Jones C</searchLink>; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Sarkar+E%22">Sarkar E</searchLink>; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Silva-Reyes+L%22">Silva-Reyes L</searchLink>; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Klenerman+P%22">Klenerman P</searchLink>; Nuffield Department of Medicine, University of Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22de+Lara+C%22">de Lara C</searchLink>; Nuffield Department of Medicine, University of Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Hutchings+C%22">Hutchings C</searchLink>; Nuffield Department of Medicine, University of Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Moris+P%22">Moris P</searchLink>; GSK, Rixensart, Belgium.<br /><searchLink fieldCode="AU" term="%22Janssens+M%22">Janssens M</searchLink>; GSK, Rixensart, Belgium.<br /><searchLink fieldCode="AU" term="%22Fissette+LA%22">Fissette LA</searchLink>; GSK, Wavre, Belgium.<br /><searchLink fieldCode="AU" term="%22Picciolato+M%22">Picciolato M</searchLink>; GSK, Rixensart, Belgium.<br /><searchLink fieldCode="AU" term="%22Leach+A%22">Leach A</searchLink>; GSK, Rockville, Maryland.<br /><searchLink fieldCode="AU" term="%22Gonzalez-Lopez+A%22">Gonzalez-Lopez A</searchLink>; GSK, Rockville, Maryland.<br /><searchLink fieldCode="AU" term="%22Dieussaert+I%22">Dieussaert I</searchLink>; GSK, Rockville, Maryland.<br /><searchLink fieldCode="AU" term="%22Snape+MD%22">Snape MD</searchLink>; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, United Kingdom.; National Institute for Health Research Oxford Biomedical Centre, United Kingdom. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229203213%22">Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</searchLink> [Clin Infect Dis] 2020 May 06; Vol. 70 (10), pp. 2073-2081. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9203213 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1537-6591 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210584838%22">10584838 </searchLink><i>NLM ISO Abbreviation: </i>Clin Infect Dis <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31340042 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/cid/ciz653 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2073 Titles: – TitleFull: First-in-Human Randomized Study to Assess the Safety and Immunogenicity of an Investigational Respiratory Syncytial Virus (RSV) Vaccine Based on Chimpanzee-Adenovirus-155 Viral Vector-Expressing RSV Fusion, Nucleocapsid, and Antitermination Viral Proteins in Healthy Adults. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Cicconi P – PersonEntity: Name: NameFull: Jones C – PersonEntity: Name: NameFull: Sarkar E – PersonEntity: Name: NameFull: Silva-Reyes L – PersonEntity: Name: NameFull: Klenerman P – PersonEntity: Name: NameFull: de Lara C – PersonEntity: Name: NameFull: Hutchings C – PersonEntity: Name: NameFull: Moris P – PersonEntity: Name: NameFull: Janssens M – PersonEntity: Name: NameFull: Fissette LA – PersonEntity: Name: NameFull: Picciolato M – PersonEntity: Name: NameFull: Leach A – PersonEntity: Name: NameFull: Gonzalez-Lopez A – PersonEntity: Name: NameFull: Dieussaert I – PersonEntity: Name: NameFull: Snape MD IsPartOfRelationships: – BibEntity: Dates: – D: 06 M: 05 Text: 2020 May 06 Type: published Y: 2020 Identifiers: – Type: issn-electronic Value: 1537-6591 Numbering: – Type: volume Value: 70 – Type: issue Value: 10 Titles: – TitleFull: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America Type: main |
| ResultId | 1 |